(HS Cabral 096252 2022) Psychedelic-Assisted Psychotherapies: A Policy Perspective
Tracking # 20-942926
Course overview
In anticipation of FDA approval and medicalization, many clinicians have jumped at the opportunity to be trained in these modalities and others are interested in learning more, but many questions remain unanswered around the current policy landscape, changes needed to welcome these medicines into our current healthcare system and in psychotherapy. This goal of this session is to provide clinicians with an overview of the history and current state of psychedelic policy and the implications for clinicians interested in practicing psychedelic-assisted therapy.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling
Certified Master Social Worker
Licensed Clinical Social Worker
Licensed Marriage and Family Therapist
Licensed Mental Health Counselor
Florida Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Florida Board of Psychology
Limited License Psychologist
Psychologist
Disclosure statements
Speaker Disclosures:
Financial: Victor Cabral is the Director of Policy and Regulatory Affairs at Fluence. He receives a speaking honorarium from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Victor Cabral is the Justice, Equity, Diversity, and Inclusion Co-Chair for the American Psychedelic Practitioners Association.